Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | VRDNViridian Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $70.85M |
| Revenue, yoy | +23,359.9% |
| Net income | $342.60M |
| Net income, yoy | −26.9% |
| Net margin | -483.6% |
| Free cash flow | $276.89M |
| FCF margin | -390.8% |
| EPS, diluted | $5.31 |
Add another company.